Big data for bipolar disorder

International Journal of Bipolar Disorders

Volumn 4, Issue 1, 2016, Pages

  Monteith, Scott ^a   Glenn, Tasha ^b   Geddes, John ^c   Whybrow, Peter C ^d   Bauer, Michael ^e  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b ChronoRecord Association Inc   (United States)

^c WARNEFORD HOSPITAL   (United Kingdom)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Big data; Bipolar disorder; Claims; EMR; Patient monitoring; Registries

Indexed keywords

C REACTIVE PROTEIN; LITHIUM; NEUROLEPTIC AGENT;

ARTIFICIAL INTELLIGENCE; AUTISM; BIPOLAR DISORDER; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CONFIDENTIALITY; ELECTRONIC MEDICAL RECORD; EPILEPSY; GENETIC HETEROGENEITY; HEALTH CARE POLICY; HUMAN; INTERNET; LIFE EXPECTANCY; LUNG EMBOLISM; MAJOR DEPRESSION; PHYSICAL DISEASE; PNEUMONIA; PREVALENCE; PRIORITY JOURNAL; PSYCHIATRIST; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SMARTPHONE; URINARY TRACT CANCER;

EID: 84992657975     PISSN: None     EISSN: 21947511     Source Type: Journal    
DOI: 10.1186/s40345-016-0051-7     Document Type: Review

References (228)

1. Abrams TE, Vaughan-Sarrazin M, Rosenthal GE. Variations in the associations between psychiatric comorbidity and hospital mortality according to the method of identifying psychiatric diagnoses. J Gen Intern Med. 2008;23:317–22.
2. Aiff H, Attman PO, Aurell M, Bendz H, Ramsauer B, Schön S, et al. Effects of 10–30 years of lithium treatment on kidney function. J Psychopharmacol. 2015;29:608–14.
3. Allebeck P. The use of population based registers in psychiatric research. Acta Psychiatr Scand. 2009;120:386–91.
4. Alvarez-Lozano J, Osmani V, Mayora O, Frost M, Bardram J, Faurholt-Jepsen M, et al. Tell me your apps and I will tell you your mood: correlation of apps usage with bipolar disorder state. In: ACM Proceedings of the 7th international conference on pervasive technologies related to assistive environments. New York: ACM; 2014. p. 19.
5. Arthur C. Google’s growing problem: 50 % of people do zero searches per day on mobile. 2015. https://www.theoverspill.wordpress.com/2015/10/19/searches-average-mobile-google-problem/. Accessed 19 Jan 2016.
6. Bagalman E, Muser E, Choi JC, Durden E, Macfadden W, Haskins JT, et al. Health care resource utilization and costs in a commercially insured population of patients with bipolar disorder type I and frequent psychiatric interventions. Clin Ther. 2011;33:1381–90.
7. Baldessarini RJ, Leahy L, Arcona S, Gause D, Zhang W, Hennen J. Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders. Psychiatr Serv. 2007;58:85–91.
8. Banaee H, Ahmed MU, Loutfi A. Data mining for wearable sensors in health monitoring systems: a review of recent trends and challenges. Sensors (Basel). 2013;13:17472–500.
9. Bauer MS, Crits-Christoph P, Ball WA, Dewees E, McAllister T, Alahi P, et al. Independent assessment of manic and depressive symptoms by self-rating. Scale characteristics and implications for the study of mania. Arch Gen Psychiatry. 1991;48:807–12.
10. Bauer M, Grof P, Gyulai L, Rasgon N, Glenn T, Whybrow PC. Using technology to improve longitudinal studies: self-reporting with ChronoRecord in bipolar disorder. Bipolar Disord. 2004;6:67–74.
11. Bauer M, Wilson T, Neuhaus K, Sasse J, Pfennig A, Lewitzka U, et al. Self-reporting software for bipolar disorder: validation of ChronoRecord by patients with mania. Psychiatry Res. 2008;159:359–66.
12. Bauer R, Glenn T, Alda M, Sagduyu K, Marsh W, Grof P, et al. Antidepressant dosage taken by patients with bipolar disorder: factors associated with irregularity. Int J Bipolar Disord. 2013a;1:26.
13. Bauer M, Glenn T, Alda M, Sagduyu K, Marsh W, Grof P, Munoz R, et al. Drug treatment patterns in bipolar disorder: analysis of long-term self-reported data. Int J Bipolar Disord. 2013b;1:5.
14. Bayley KB, Belnap T, Savitz L, Masica AL, Shah N, Fleming NS. Challenges in using electronic health record data for CER: experience of four learning organizations and solutions applied. Med Care. 2013;51(8 Suppl 3):S80–6.
15. Berger ML, Doban V. Big data, advanced analytics and the future of comparative effectiveness research. J Comp Eff Res. 2014;3:167–76.
16. Bilton N. Data without context tells a misleading story. The New York Times. 2013. http://www.bits.blogs.nytimes.com/2013/02/24/disruptions-google-flu-trends-shows-problems-of-big-data-without-context/?_r=0. Accessed 19 Jan 2016.
17. Binder H, Blettner M. Big data in medical science–a biostatistical view. Dtsch Arztebl Int. 2015;112:137–42.
18. Bjørklund L, Horsdal HT, Mors O, Østergaard SD, Gasse C. Trends in the psychopharmacological treatment of bipolar disorder: a nationwide register-based study. Acta Neuropsychiatr. 2015;11:1–10.
19. Blair DR, Lyttle CS, Mortensen JM, Bearden CF, Jensen AB, Khiabanian H, et al. A nondegenerate code of deleterious variants in Mendelian loci contributes to complex disease risk. Cell. 2013;155:70–80.
20. Bloechliger M, Rüegg S, Jick SS, Meier CR, Bodmer M. Antipsychotic drug use and the risk of seizures: follow-up study with a nested case-control analysis. CNS Drugs. 2015;29:591–603.
21. Bocchetta A, Ardau R, Fanni T, Sardu C, Piras D, Pani A, et al. Renal function during long-term lithium treatment: a cross-sectional and longitudinal study. BMC Med. 2015;13:12.
22. Bopp JM, Miklowitz DJ, Goodwin GM, Stevens W, Rendell JM, Geddes JR. The longitudinal course of bipolar disorder as revealed through weekly text messaging: a feasibility study. Bipolar Disord. 2010;12:327–34.
23. Boulden, J. Will artificial intelligence kill the smartphone? CNN Money. 2015. http://www.money.cnn.com/2015/12/09/technology/ericsson-survey-predicts-smartphone-death/. Accessed 19 Jan 2016.
24. Boyd D, Crawford K. Critical questions for big data: provocations for a cultural, technological, and scholarly phenomenon. Inf Commun Soc. 2012;15:662–79.
25. Brown JD, Barrett A, Caffery E, Hourihan K, Ireys HT. Medication continuity among medicaid beneficiaries with schizophrenia and bipolar disorder. Psychiatr Serv. 2013;64:878–85.
26. Brown JD, Barrett A, Hourihan K, Caffery E, Ireys HT. State variation in the delivery of comprehensive services for medicaid beneficiaries with schizophrenia and bipolar disorder. Community Ment Health J. 2015;51:523–34.
27. Burkhardt P. An overview of big data, vol. 20. Dayton: The Next Wave; 2014. p. 1–7.
28. Butler M, Kane RL, McAlpine D, Kathol RG, Fu SS, Hagedorn H, et al. Integration of mental health/substance abuse and primary care. Evid Rep Technol Assess (Full Rep). 2008;173:1–362.
29. Byrne N, Regan C, Howard L. Administrative registers in psychiatric research: a systematic review of validity studies. Acta Psychiatr Scand. 2005;112:409–14.
30. Cai X, Li Y. Are AMI patients with comorbid mental illness more likely to be admitted to hospitals with lower quality of AMI care. PLoS One. 2013;8:e60258.
31. Calkin CV, Alda M. Insulin resistance in bipolar disorder: relevance to routine clinical care. Bipolar Disord. 2015;17:683–8.
32. Calkin CV, Ruzickova M, Uher R, Hajek T, Slaney CM, Garnham JS, et al. Insulin resistance and outcome in bipolar disorder. Br J Psychiatry. 2015;206:52–7.
33. Carlborg A, Ferntoft L, Thuresson M, Bodegard J. Population study of disease burden, management, and treatment of bipolar disorder in Sweden: a retrospective observational registry study. Bipolar Disord. 2015;17:76–85.
34. Carney CP, Jones LE. Medical comorbidity in women and men with bipolar disorders: a population-based controlled study. Psychosom Med. 2006;68:684–91.
35. Castro VM, Minnier J, Murphy SN, Kohane I, Churchill SE, Gainer V, et al. Validation of electronic health record phenotyping of bipolar disorder cases and controls. Am J Psychiatry. 2015;172:363–72.
36. Castro VM, Roberson AM, McCoy TH, Wiste A, Cagan A, Smoller JW, et al. Stratifying risk for renal insufficiency among lithium-treated patients: an electronic health record study. Neuropsychopharmacology. 2016;41(4):1138–43 (Epub ahead of print).
37. Cerimele JM, Strain JJ. Integrating primary care services into psychiatric care settings: a review of the literature. Prim Care Companion J Clin Psychiatry. 2010;12(6). doi:10.4088/PCC.10r00971whi
38. Chan EW, Liu KQ, Chui CS, Sing CW, Wong LY, Wong IC. Adverse drug reactions-examples of detection of rare events using databases. Br J Clin Pharmacol. 2015;80:855–61.
39. Chang CK, Hayes RD, Perera G, Broadbent MT, Fernandes AC, Lee WE, et al. Life expectancy at birth for people with serious mental illness and other major disorders from a secondary mental health care case register in London. PLoS One. 2011;6:e19590.
40. Chen W, Deveaugh-Geiss AM, Palmer L, Princic N, Chen YT. Patterns of atypical antipsychotic therapy use in adults with bipolar I disorder in the USA. Hum Psychopharmacol. 2013;28:428–37.
41. Clarke MC, Tanskanen A, Huttunen MO, Clancy M, Cotter DR, Cannon M. Evidence for shared susceptibility to epilepsy and psychosis: a population-based family study. Biol Psychiatry. 2012;71:836–9.
42. Clemens NA. Privacy, consent, and the electronic mental health record: the person vs. the system. J Psychiatr Pract. 2012;18:46–50.
43. Clemente AS, Diniz BS, Nicolato R, Kapczinski FP, Soares JC, Firmo JO, et al. Bipolar disorder prevalence: a systematic review and meta-analysis of the literature. Rev Bras Psiquiatr. 2015;37:155–61.
44. Clos S, Rauchhaus P, Severn A, Cochrane L, Donnan PT. Long-term effect of lithium maintenance therapy on estimated glomerular filtration rate in patients with affective disorders: a population-based cohort study. Lancet Psychiatry. 2015;2:1075–83.
45. Close H, Reilly J, Mason JM, Kripalani M, Wilson D, Main J, Hungin AP. Renal failure in lithium-treated bipolar disorder: a retrospective cohort study. PLoS One. 2014;9(3):e90169.
46. Conti V, Venegoni M, Cocci A, Fortino I, Lora A, Barbui C. Antipsychotic drug exposure and risk of pulmonary embolism: a population-based, nested case-control study. BMC Psychiatry. 2015;15:92.
47. Conus P, Macneil C, McGorry PD. Public health significance of bipolar disorder: implications for early intervention and prevention. Bipolar Disord. 2014;16:548–56.
48. Coppersmith G, Dredze M, Harman C, Hollingshead K. From ADHD to SAD: analyzing the language of mental health on Twitter through self-reported diagnoses. In: Proceedings of the 2nd workshop on computational linguistics and clinical psychology: from linguistic signal to clinical reality. Denver: North American Chapter of the Association for Computational Linguistics 2015.
49. Crawford K. The hidden biases in big data. Harvard Business Review. 2013. https://www.hbr.org/2013/04/the-hidden-biases-in-big-data. Accessed 19 Jan 2016.
50. Crump C, Ioannidis JP, Sundquist K, Winkleby MA, Sundquist J. Mortality in persons with mental disorders is substantially overestimated using inpatient psychiatric diagnoses. J Psychiatr Res. 2013a;47:1298–303.
51. Crump C, Sundquist K, Winkleby MA, Sundquist J. Comorbidities and mortality in bipolar disorder: a Swedish national cohort study. JAMA Psychiatry. 2013b;70:931–9.
52. Curtis M. New data sources: a conversation with Google’s Hal Varian. Federal Reserve Bank of Atlanta. 2014. http://www.macroblog.typepad.com/macroblog/2014/04/new-data-sources-a-conversation-with-googles-hal-varian.html. Accessed 19 Jan 2016.
53. Daglas R, Yücel M, Cotton S, Allott K, Hetrick S, Berk M. Cognitive impairment in first-episode mania: a systematic review of the evidence in the acute and remission phases of the illness. Int J Bipolar Disord. 2015;25(3):9.
54. Davenport T. Big data at work: dispelling the myths, uncovering the opportunities. New York: Harvard Business Review Press; 2014. p. 43.
55. D’Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: the Framingham heart study. Circulation. 2008;117:743–53.
56. Datta R, Li J, Wang JZ. Exploiting the human-machine gap in image recognition for designing CAPTCHAs. IEEE Trans Inf Forensics Secur. 2009;4:504–18.
57. Davidson M, Kapara O, Goldberg S, Yoffe R, Noy S, Weiser M. A nation-wide study on the percentage of schizophrenia and bipolar disorder patients who earn minimum wage or above. Schizophr Bull. 2016;42(2):443–7 (Epub ahead of print).
58. De Hert M, Correll CU, Bobes J, Cetkovich-Bakmas M, Cohen D, Asai I, et al. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry. 2011;10:52–77.
59. de Lissovoy G. Big data meets the electronic medical record: a commentary on “identifying patients at increased risk for unplanned readmission”. Med Care. 2013;51:759–60.
60. DeShazo JP, Hoffman MA. A comparison of a multistate inpatient EHR database to the HCUP Nationwide inpatient sample. BMC Health Serv Res. 2015;15:384.
61. Dinov ID. Methodological challenges and analytic opportunities for modeling and interpreting big healthcare data. Gigascience. 2016;5:12.
62. Dove ES, Phillips M. Privacy law, data sharing policies, and medical data: a comparative perspective. In: Gkoulalas-Divanis A, Loukides, editors. Medical data privacy handbook. Berlin: Springer International Publishing; 2015. p. 639–78.
63. Druss BG, Zhao L, Von Esenwein S, Morrato EH, Marcus SC. Understanding excess mortality in persons with mental illness: 17-year follow up of a nationally representative US survey. Med Care. 2011;49:599–604.
64. Elgan M. The dark side of the coming chatbot revolution. Computerworld. 2015. http://www.computerworld.com/article/3018162/emerging-technology/the-dark-side-of-the-coming-chatbot-revolution.html. Accessed 19 Jan 2016.
65. Experian 2015 Data Breach Industry Forecast. 2015. http://www.experian.com/assets/data-breach/white-papers/2016-experian-data-breach-industry-forecast.pdf. Accessed 19 Jan 2016.
66. Fan J, Han F, Liu H. Challenges of big data analysis. Natl Sci Rev. 2014;1:293–314.
67. Faurholt-Jepsen M, Vinberg M, Frost M, Christensen EM, Bardram JE, Kessing LV. Smartphone data as an electronic biomarker of illness activity in bipolar disorder. Bipolar Disord. 2015;17:715–28.
68. Fernald J, Wang B. The recent rise and fall of rapid productivity growth. Federal Reserve Bank of San Francisco Economic Letter. 2015. http://www.frbsf.org/economic-research/publications/economic-letter/2015/february/economic-growth-information-technology-factor-productivity/. Accessed 19 Jan 2016.
69. Fiest KM, Jette N, Quan H, St Germaine-Smith C, Metcalfe A, Patten SB, et al. Systematic review and assessment of validated case definitions for depression in administrative data. BMC Psychiatry. 2014;14:289.
70. Fontanella CA, Hiance-Steelesmith DL, Gilchrist R, Bridge JA, Weston D II, Campo JV. Quality of care for medicaid-enrolled youth with bipolar disorders. Adm Policy Ment Health. 2015;42:126–38.
71. FTC (US Federal Trade Commission). Self-regulatory principles for online behavioral advertising. 2009. https://www.ftc.gov/sites/default/files/documents/reports/federal-trade-commission-staff-report-self-regulatory-principles-online-behavioral-advertising/p085400behavadreport.pdf. Accessed 19 Jan 2016.
72. Gale CR, Batty GD, McIntosh AM, Porteous DJ, Deary IJ, Rasmussen F. Is bipolar disorder more common in highly intelligent people? A cohort study of a million men. Mol Psychiatry. 2013;18:190–4.
73. Geller T. How do you feel? Your computer knows. Commun ACM. 2014;57:24–6.
74. Glenn T, Monteith S. New measures of mental state and behavior based on data collected from sensors, smartphones, and the internet. Curr Psychiatry Rep. 2014a;16:523.
75. Glenn T, Monteith S. Privacy in the digital world: medical and health data outside of HIPAA protections. Curr Psychiatry Rep. 2014b;16:494.
76. Gold L, Ayers D, Bertino J, Bock C, Bock A, Brody EN, et al. Aptamer-based multiplexed proteomic technology for biomarker discovery. PLoS One. 2010;5:e15004.
77. Goldstein BA, Winkelmayer WC. Comparative health services research across populations: the unused opportunities in big data. Kidney Int. 2015;87:1094–6.
78. Goldstein BI, Schaffer A, Wang S, Blanco C. Excessive and premature new-onset cardiovascular disease among adults with bipolar disorder in the US NESARC cohort. J Clin Psychiatry. 2015;76:163–9.
79. Grande D, Mitra N, Shah A, Wan F, Asch DA. Public preferences about secondary uses of electronic health information. JAMA Intern Med. 2013;28(173):1798–806.
80. Grant BF, Stinson FS, Dawson DA, Chou SP, Dufour MC, Compton W, et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on alcohol and related conditions. Arch Gen Psychiatry. 2004;61:807–16.
81. Grimes DA, Schulz KF. Bias and causal associations in observational research. Lancet. 2002;359:248–52.
82. Gruenerbl A, Osmani V, Bahle G, Carrasco JC, Oehler S, Mayora O, et al. Using smart phone mobility traces for the diagnosis of depressive and manic episodes in bipolar patients. In: ACM Proceedings of the 5th augmented human international conference. 2014. p. 38.
83. Guszcza J, Richardson B. Two dogmas of big data: understanding the power of analytics for predicting human behavior. Deloitte Rev. 2014;18:161–75.
84. Hamalka J. The cost of storing patient records. http://www.geekdoctor.blogspot.com/2011/04/cost-of-storing-patient-records.html. Accessed 8 Mar 2016.
85. Hamilton JE, Passos IC, de Azevedo Cardoso T, Jansen K, Allen M, Begley CE, et al. Predictors of psychiatric readmission among patients with bipolar disorder at an academic safety-net hospital. Aust N Z J Psychiatry. 2015. doi:10.1177/0004867415605171[Epub ahead of print].
86. Hampton LM, Daubresse M, Chang HY, Alexander GC, Budnitz DS. Emergency department visits by adults for psychiatric medication adverse events. JAMA Psychiatry. 2014;71:1006–14.
87. Hand DJ. Data, not dogma: big data, open data, and the opportunities ahead. In: Tucker A, Höppner F, Siebes A, Swift S, editors. Advances in intelligent data analysis XII. Berlin: Springer; 2013. p. 1–12.
88. Hardy S, Hinks P, Gray R. Screening for cardiovascular risk in patients with severe mental illness in primary care: a comparison with patients with diabetes. J Ment Health. 2013;22:42–50.
89. Harris GT, Lowenkamp CT, Hilton NZ. Evidence for risk estimate precision: implications for individual risk communication. Behav Sci Law. 2015;33:111–27.
90. Haupt DW, Rosenblatt LC, Kim E, Baker RA, Whitehead R, Newcomer JW. Prevalence and predictors of lipid and glucose monitoring in commercially insured patients treated with second-generation antipsychotic agents. Am J Psychiatry. 2009;166:345–53.
91. Hayes J, Prah P, Nazareth I, King M, Walters K, Petersen I, et al. Prescribing trends in bipolar disorder: cohort study in the United Kingdom THIN primary care database 1995–2009. PLoS One. 2011;6:e28725.
92. HCUP Databases. Healthcare cost and utilization project (HCUP—US). 2015. Rockville: Agency for Healthcare Research and Quality. http://www.hcup-us.ahrq.gov/nisoverview.jsp. Accessed 19 Jan 2016.
93. HealthIT.gov. A shared nationwide interoperability roadmap version 1.0. 2015. https://www.healthit.gov/policy-researchers-implementers/interoperability. Accessed 8 Mar 2016.
94. Hersh WR, Weiner MG, Embi PJ, Logan JR, Payne PR, Bernstam EV, et al. Caveats for the use of operational electronic health record data in comparative effectiveness research. Med Care. 2013;51(8 Suppl 3):S30–7.
95. Hibar DP, Westlye LT, TGM van Erp TGM, Rasmussen J, Leonardo CD, Faskowitz J, et al. Subcortical volumetric abnormalities in bipolar disorder. Mol Psychiatry. 2016. doi:10.1038/mp.2015.227
96. Hjorthøj C, Østergaard ML, Benros ME, Toftdahl NG, Erlangsen A, Andersen JT, et al. Association between alcohol and substance use disorders and all-cause and cause-specific mortality in schizophrenia, bipolar disorder, and unipolar depression: a nationwide, prospective, register-based study. Lancet Psychiatry. 2015;2:801–8.
97. Hoang U, Stewart R, Goldacre MJ. Mortality after hospital discharge for people with schizophrenia or bipolar disorder: retrospective study of linked English hospital episode statistics, 1999–2006. BMJ. 2011;343:d5422.
98. Hochster HS, Niedzwiecki D. Big data, small effects. J Clin Oncol. 2016. doi:10.1200/JCO.2015.65.8161.
99. Hoertel N, Limosin F, Leleu H. Poor longitudinal continuity of care is associated with an increased mortality rate among patients with mental disorders: results from the French National Health Insurance Reimbursement Database. Eur Psychiatry. 2014;29:358–64.
100. Horvitz E, Mulligan D. Data, privacy, and the greater good. Science. 2015;349:253–5.
101. Hou L, Heilbronner U, Degenhardt F, Adli M, Akiyama K, Akula N, et al. Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study. Lancet. 2016;387:1085–93.
102. Horrigan MW. Big data: a perspective from the BLS. Amstat news. http://www.magazine.amstat.org/blog/2013/01/01/sci-policy-jan2013/. Accessed 19 Jan 2016.
103. Hripcsak G, Knirsch C, Zhou L, Wilcox A, Melton G. Bias associated with mining electronic health records. J Biomed Discov Collab. 2011;6:48–52.
104. Hripcsak G, Albers DJ. Next-generation phenotyping of electronic health records. J Am Med Inform Assoc. 2013;20:117–21.
105. Huckvale K, Prieto JT, Tilney M, Benghozi PJ, Car J. Unaddressed privacy risks in accredited health and wellness apps: a cross-sectional systematic assessment. BMC Med. 2015;13:214.
106. IBM. IBM and partners to transform personal health with Watson and Open Cloud. 2015a. https://www-03.ibm.com/press/us/en/pressrelease/46580.wss. Accessed 19 Jan 2016.
107. IBM. Leading in the era of cognitive business. 2015b. https://www.think-exchange.com/wp-content/uploads/CIO-Leadership-Exchange-eBook.pdf. Accessed 8 Mar 2016.
108. IHE. Integrating the healthcare enterprise (IHE). 2015. http://www.ihe.net/ Accessed 8 Mar 2016.
109. Insel TR. Translating scientific opportunity into public health impact: a strategic plan for research on mental illness. Arch Gen Psychiatry. 2009;66:128–33.
110. Insel TR. The NIMH research domain criteria (RDoC) project: precision medicine for psychiatry. Am J Psychiatry. 2014;171(4):395–7.
111. Ivanović M, Budimac Z. An overview of ontologies and data resources in medical domains. Expert Syst Appl. 2014;1(41):5158–66.
112. Jiang Y, Ni W. Estimating the impact of adherence to and persistence with atypical antipsychotic therapy on health care costs and risk of hospitalization. Pharmacotherapy. 2015;35:813–22.
113. Kane JM, Perlis RH, DiCarlo LA, Au-Yeung K, Duong J, Petrides G. First experience with a wireless system incorporating physiologic assessments and direct confirmation of digital tablet ingestions in ambulatory patients with schizophrenia or bipolar disorder. J Clin Psychiatry. 2013;74:e533–40.
114. Kaplan RM, Chambers DA, Glasgow RE. Big data and large sample size: a cautionary note on the potential for bias. Clin Transl Sci. 2014;7:342–6.
115. Karam ZN, Provost EM, Singh S, Montgomery J, Archer C, Harrington G, et al. Ecologically valid long-term mood monitoring of individuals with bipolar disorder using speech. In: IEEE International Conference on acoustics, speech and signal processing (ICASSP). Florence: IEEE; 2014. p. 4858–4862.
116. Katon WJ, Lin EH, Von Korff M, Ciechanowski P, Ludman EJ, Young B, et al. Collaborative care for patients with depression and chronic illnesses. N Engl J Med. 2010;363:2611–20.
117. Kessing LV, Gerds TA, Feldt-Rasmussen B, Andersen PK, Licht RW. Use of lithium and anticonvulsants and the rate of chronic kidney disease: a Nationwide Population-Based Study. JAMA Psychiatry. 2015a;72:1182–91.
118. Kessing LV, Gerds TA, Feldt-Rasmussen B, Andersen PK, Licht RW. Lithium and renal and upper urinary tract tumors - results from a nationwide population-based study. Bipolar Disord. 2015b;17:805–13.
119. Kessing LV, Vradi E, Andersen PK. Life expectancy in bipolar disorder. Bipolar Disord. 2015c;17:543–8.
120. Kessing LV, Vradi E, McIntyre RS, Andersen PK. Causes of decreased life expectancy over the life span in bipolar disorder. J Affect Disord. 2015d;180:142–7.
121. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51:8–19.
122. Kleine-Budde K, Touil E, Moock J, Bramesfeld A, Kawohl W, Rössler W. Cost of illness for bipolar disorder: a systematic review of the economic burden. Bipolar Disord. 2014;16:337–53.
123. Khoury MJ, Ioannidis JP. Medicine. Big data meets public health. Science. 2014;346:1054–5.
124. Ko J, Lu C, Srivastava MB, Stankovic J, Terzis A, Welsh M. Wireless sensor networks for healthcare. Proc IEEE. 2010;98:1947–60.
125. Kupka RW, Altshuler LL, Nolen WA, Suppes T, Luckenbaugh DA, Leverich GS, et al. Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder1. Bipolar Disord. 2007;9:531–5.
126. Kyaga S, Lichtenstein P, Boman M, Landén M. Bipolar disorder and leadership–a total population study. Acta Psychiatr Scand. 2015;131:111–9.
127. Landauer TK. The trouble with computers: usefulness, usability, and productivity, vol. 21. Cambridge: MIT press; 1995.
128. Larson EB. Building trust in the power of “big data” research to serve the public good. JAMA. 2013;309:2443–4.
129. Laursen TM, Munk-Olsen T, Nordentoft M, Mortensen PB. Increased mortality among patients admitted with major psychiatric disorders: a register-based study comparing mortality in unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia. J Clin Psychiatry. 2007;68:899–907.
130. Laursen TM, Munk-Olsen T, Agerbo E, Gasse C, Mortensen PB. Somatic hospital contacts, invasive cardiac procedures, and mortality from heart disease in patients with severe mental disorder. Arch Gen Psychiatry. 2009;66:713–20.
131. Laursen TM, Mortensen PB, MacCabe JH, Cohen D, Gasse C. Cardiovascular drug use and mortality in patients with schizophrenia or bipolar disorder: a Danish population-based study. Psychol Med. 2014;44:1625–37.
132. Lazer D, Kennedy R, King G, Vespignani A. The parable of Google Flu: traps in big data analysis. Science. 2014a;343:1203–5.
133. Lazer D, Kennedy R, King G, Vespignani A. Google flu trends still appears sick: an evaluation of the 2013–2014 flu season. 2014b. http://www.dx.doi.org/10.2139/ssrn.2408560. Accessed 19 Jan 2016.
134. Li X, Shen C. Linkage of patient records from disparate sources. Stat Methods Med Res. 2013;22:31–8.
135. Lyalina S, Percha B, LePendu P, Iyer SV, Altman RB, Shah NH. Identifying phenotypic signatures of neuropsychiatric disorders from electronic medical records. J Am Med Inform Assoc. 2013;20:e297–305.
136. Mabry PL, Olster DH, Morgan GD, Abrams DB. Interdisciplinarity and systems science to improve population health: a view from the NIH Office of behavioral and social sciences research. Am J Prev Med. 2008;35(2 Suppl):S211–24.
137. MacMillan D. Mobile search tops at google. Wall street journal. (WSJ.D). 2015. http://www.blogs.wsj.com/digits/2015/10/08/google-says-mobile-searches-surpass-those-on-pcs/. Accessed 19 Jan 2016.
138. Madigan D, Ryan PB, Schuemie M, Stang PE, Overhage JM, Hartzema AG, et al. Evaluating the impact of database heterogeneity on observational study results. Am J Epidemiol. 2013;178:645–51.
139. Mahoney MW, Lim LH, Carlsson GE. Algorithmic and statistical challenges in modern large-scale data analysis are the focus of MMDS (modern massive data sets). 2008. http://www.arxiv.org/abs/0812.3702. Accessed 19 Jan 2016.
140. Manderscheid R, Kathol R. Fostering sustainable, integrated medical and behavioral health services in medical settings. Ann Intern Med. 2014;160:61–5.
141. Mangurian C, Newcomer JW, Vittinghoff E, Creasman JM, Knapp P, Fuentes-Afflick E, et al. Diabetes screening among underserved adults with severe mental illness who take antipsychotic medications. JAMA Intern Med. 2015;175:1977–9.
142. Marewski JN, Gigerenzer G. Heuristic decision making in medicine. Dialogues Clin Neurosci. 2012;14:77–89.
143. Marketscan. Health research data for the real world: the MarketScan databases. Truven Health Analytics. 2011. http://www.truvenhealth.com/portals/0/assets/PH_11238_0612_TEMP_MarketScan_WP_FINAL.pdf. Accessed 19 Jan 2016.
144. McAfee A, Brynjolfsson E, Davenport TH, Patil DJ, Barton D. Big data: the management revolution. Harvard Bus Rev. 2012;90:61–7.
145. McCarthy JF, Bossarte RM, Katz IR, Thompson C, Kemp J, Hannemann CM, et al. Predictive modeling and concentration of the risk of suicide: implications for preventive interventions in the US Department of Veterans Affairs. Am J Public Health. 2015;105:1935–42.
146. McGinty EE, Baller J, Azrin ST, Juliano-Bult D, Daumit GL. Quality of medical care for persons with serious mental illness: a comprehensive review. Schizophrenia Res. 2015;165:227–35.
147. McGraw D. Building public trust in uses of Health Insurance Portability and Accountability Act de-identified data. J Am Med Inform Assoc. 2013;20:29–34.
148. Medicaid. Medicaid.gov by population. 2015. http://www.medicaid.gov/medicaid-chip-program-information/by-population/by-population.html. Accessed 19 Jan 2016.
149. Melek SP, Norris DT, Paulus J. Economic impact of integrated medical-behavioral healthcare. Milliman Am Psychiatr Assoc Rep. 2014.
150. Mitchell AJ, Hardy SA. Screening for metabolic risk among patients with severe mental illness and diabetes: a national comparison. Psychiatr Serv. 2013;64:1060–3.
151. Monteith S, Glenn T, Geddes J, Bauer M. Big data are coming to psychiatry: a general introduction. Int J Bipolar Disord. 2015;3(1):21.
152. Moons KG, Kengne AP, Woodward M, Royston P, Vergouwe Y, Altman DG, et al. Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio) marker. Heart. 2012;98:683–90.
153. Moore PJ, Little MA, McSharry PE, Goodwin GM, Geddes JR. Mood dynamics in bipolar disorder. Int J Bipolar Disord. 2014;2:11.
154. Mortensen PB, Pedersen CB, McGrath JJ, Hougaard DM, Nørgaard-Petersen B, Mors O, et al. Neonatal antibodies to infectious agents and risk of bipolar disorder: a population-based case-control study. Bipolar Disord. 2011;13:624–9.
155. Muaremi A, Gravenhorst F, Grünerbl A, Arnrich B, Tröster G. Assessing bipolar episodes using speech cues derived from phone calls. In: Cipresso P, Lopez G, Matic A, editors. Pervasive computing paradigms for mental health. Springer; 2014. p. 103–14.
156. Muench F. The promises and pitfalls of digital technology in its application to alcohol treatment. Alcohol Res. 2014;36:131–42.
157. Munk-Jørgensen P, Okkels N, Golberg D, Ruggeri M, Thornicroft G. Fifty years’ development and future perspectives of psychiatric register research. Acta Psychiatr Scand. 2014;130:87–98.
158. Narayanan A, Huey J, Felten EW. A precautionary approach to big data privacy. In: Gutwirth S, Leenes R, De Hert P, editors. Data protection on the move. Netherlands: Springer; 2016. p. 357–85.
159. Nguyen T, O’Dea B, Larsen M, Phung D, Venkatesh S, Christensen H. Differentiating sub-groups of online depression-related communities using textual cues. In: Wang J, Cellary W, Wang D, Wang H, Chen S-C, Li T, Zhang Y, editors. Web information systems engineering–WISE. Springer; 2015. p. 216–24.
160. NRC (National Research Council US) commititee on the analysis of massive data. Frontiers in massive data analysis. 2013. http://www.nap.edu/catalog/18374/frontiers-in-massive-data-analysis. Accessed 19 Jan 2016.
161. Øiesvold T, Nivison M, Hansen V, Skre I, Ostensen L, Sørgaard KW. Diagnosing comorbidity in psychiatric hospital: challenging the validity of administrative registers. BMC Psychiatry. 2013;13:13.
162. Øiesvold T, Nivison M, Hansen V, Sørgaard KW, Østensen L, Skre I. Classification of bipolar disorder in psychiatric hospital. A prospective cohort study. BMC Psychiatry. 2012;12:13.
163. Osborn DP, Hardoon S, Omar RZ, Holt RI, King M, Larsen J, et al. Cardiovascular risk prediction models for people with severe mental illness: results from the prediction and management of cardiovascular risk in people with severe mental illnesses (PRIMROSE) research program. JAMA Psychiatry. 2015;72:143–51.
164. Osmani V, Maxhuni A, Grünerbl A, Lukowicz P, Haring C, Mayora O. Monitoring activity of patients with bipolar disorder using smart phones. In: ACM Proceedings of international conference on advances in mobile computing and multimedia. New York: ACM; 2013. p. 85.
165. Overhage JM, Overhage LM. Sensible use of observational clinical data. Stat Methods Med Res. 2013;22:7–13.
166. Page L. Google 2013 founders letter to investors. Google. 2013. http://www.investor.google.com/corporate/2013/founders-letter.html. Accessed 19 Jan 2016.
167. Paksarian D, Eaton WW, Mortensen PB, Merikangas KR, Pedersen CB. A population-based study of the risk of schizophrenia and bipolar disorder associated with parent-child separation during development. Psychol Med. 2015;45:2825–37.
168. Patel CJ, Burford B, Ioannidis JP. Assessment of vibration of effects due to model specification can demonstrate the instability of observational associations. J Clin Epidemiol. 2015a;68:1046–58.
169. Patel R, Shetty H, Jackson R, Broadbent M, Stewart R, Boydell J, et al. Delays before diagnosis and initiation of treatment in patients presenting to mental health services with bipolar disorder. PLoS One. 2015b;10:e0126530.
170. Pathak J, Kho AN, Denny JC. Electronic health records-driven phenotyping: challenges, recent advances, and perspectives. J Am Med Inform Assoc. 2013;20:e206–11.
171. Paxton C, Niculescu-Mizil A, Saria S. Developing predictive models using electronic medical records: challenges and pitfalls. AMIA Annu Symp Proc. 2013;2013:1109–15.
172. Piette JD, Sussman JB, Pfeiffer PN, Silveira MJ, Singh S, Lavieri MS. Maximizing the value of mobile health monitoring by avoiding redundant patient reports: prediction of depression-related symptoms and adherence problems in automated health assessment services. J Med Internet Res. 2013;15:e118.
173. Poluzzi E, Raschi E, Koci A, Moretti U, Spina E, Behr ER, et al. Antipsychotics and torsadogenic risk: signals emerging from the US FDA adverse event reporting system database. Drug Saf. 2013;36:467–79.
174. Pope C, Halford S, Tinati R, Weal M. What’s the big fuss about ‘big data’? J Health Serv Res Policy. 2014;19:67–8.
175. Potash JB. Electronic medical records: fast track to big data in bipolar disorder. Am J Psychiatry. 2015;172:310–1.
176. Pottegård A, Hallas J, Jensen BL, Madsen K, Friis S. Long-term lithium use and risk of renal and upper urinary tract cancers. J Am Soc Nephrol. 2016;27:249–55.
177. President’s council of advisors on science and technology. Big data and privacy: a technological Perspective. 2014. http://www.whitehouse.gov/sites/default/files/microsites/ostp/PCAST/pcast_big_data_and_privacy_-_may_2014.pdf. Accessed 19 Jan 2016.
178. Redmond SJ, Lovell NH, Yang GZ, Horsch A, Lukowicz P, Murrugarra L, et al. What does big data mean for wearable sensor systems? Contribution of the IMIA wearable sensors in healthcare WG. Yearb Med Inform. 2014;9:135–42.
179. Reynolds CF III, Lewis DA, Detre T, Schatzberg AF, Kupfer DJ. The future of psychiatry as clinical neuroscience. Acad Med. 2009;84:446.
180. Riley GF. Administrative and claims records as sources of health care cost data. Med Care. 2009;47(7 Suppl 1):S51–5.
181. Robertson AG, Swanson JW, Frisman LK, Lin H, Swartz MS. Patterns of justice involvement among adults with schizophrenia and bipolar disorder: key risk factors. Psychiatr Serv. 2014;65:931–8.
182. Rodriguez EM, Staffa JA, Graham DJ. The role of databases in drug postmarketing surveillance. Pharmacoepidemiol Drug Saf. 2001;10:407–10.
183. Rose G. Sick individuals and sick populations. Int J Epidemiol. 2001;30:427–32.
184. Roshanaei-Moghaddam B, Katon W. Premature mortality from general medical illnesses among persons with bipolar disorder: a review. Psychiatr Serv. 2009;60:147–56.
185. Rothstein MA. Ethical issues in big data health research: currents in contemporary bioethics. J Law Med Ethics. 2015;43:425–9.
186. Sarrazin MS, Rosenthal GE. Finding pure and simple truths with administrative data. JAMA. 2012;307:1433–5.
187. Schärer LO, Krienke UJ, Graf SM, Meltzer K, Langosch JM. Validation of life-charts documented with the personal life-chart app - a self-monitoring tool for bipolar disorder. BMC Psychiatry. 2015;15:49.
188. Seabury SA, Goldman DP, Kalsekar I, Sheehan JJ, Laubmeier K, Lakdawalla DN. Formulary restrictions on atypical antipsychotics: impact on costs for patients with schizophrenia and bipolar disorder in medicaid. Am J Manag Care. 2014;20:e52–60.
189. Selten JP, Lundberg M, Rai D, Magnusson C. Risks for nonaffective psychotic disorder and bipolar disorder in young people with autism spectrum disorder: a population-based study. JAMA Psychiatry. 2015;72:483–9.
190. Shine B, McKnight RF, Leaver L, Geddes JR. Long-term effects of lithium on renal, thyroid, and parathyroid function: a retrospective analysis of laboratory data. Lancet. 2015;386:461–8.
191. Shippee ND, Shah ND, Williams MD, Moriarty JP, Frye MA, Ziegenfuss JY. Differences in demographic composition and in work, social, and functional limitations among the populations with unipolar depression and bipolar disorder: results from a nationally representative sample. Health Qual Life Outcomes. 2011;9:90.
192. Simonite T. Facebook joins stampede of tech giants giving away artificial intelligence technology. MIT Technol Rev. 2015. http://www.technologyreview.com/news/544236/facebook-joins-stampede-of-tech-giants-giving-away-artificial-intelligence-technology/. Accessed 19 Jan 2016.
193. Singh A, Nadkarni G, Gottesman O, Ellis SB, Bottinger EP, Guttag JV. Incorporating temporal EHR data in predictive models for risk stratification of renal function deterioration. J Biomed Inform. 2015;53:220–8.
194. Singh JP, Fazel S, Gueorguieva R, Buchanan A. Rates of violence in patients classified as high risk by structured risk assessment instruments. Br J Psychiatry. 2014;204:180–7.
195. Sklar P, Ripke S, Scott LJ, Andreassen OA, Cichon S, Craddock N, et al. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet. 2011;43:977–83.
196. Slabodkin G. IBM CEO: Watson health is ‘our moonshot’ in healthcare. 2015. http://www.thoughtsoncloud.com/2015/04/ibm-ceo-watson-health-is-our-moonshot-in-healthcare/. Accessed 8 Mar 2016.
197. Smith A. US smartphone use in 2015. Pew research. 2015. http://www.pewinternet.org/2015/04/01/us-smartphone-use-in-2015/. Accessed 19 Jan 2016.
198. Smith DJ, Martin D, McLean G, Langan J, Guthrie B, Mercer SW. Multimorbidity in bipolar disorder and undertreatment of cardiovascular disease: a cross sectional study. BMC Med. 2013;11:263.
199. Smith DJ, Anderson J, Zammit S, Meyer TD, Pell JP, Mackay D. Childhood IQ and risk of bipolar disorder in adulthood: prospective birth cohort study. Br J Psychiatry Open. 2015;1:74–80.
200. SomaLogic. 2016. http://www.somalogic.com. Accessed 19 Jan 2016.
201. Starren J, Williams MS, Bottinger EP. Crossing the omic chasm: a time for omic ancillary systems. JAMA. 2013;309:1237–8.
202. Stewart R, Soremekun M, Perera G, Broadbent M, Callard F, Denis M, et al. The South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLAM BRC) case register: development and descriptive data. BMC Psychiatry. 2009;9:51.
203. Sung I. The impact of health care reform on insurance switching patterns. Athenahealth. 2015. http://www.athenahealth.com/blog/2015/07/16/acaview-research-brief-the-impact-of-health-care-reform-on-insurance-switching-patterns. Accessed 19 Jan 2016.
204. Thomas D. Smartphone makers look to other products s saturation looms. Financial Times. 2014. http://www.ft.com/cms/s/0/ed881b3a-f487-11e3-a143-00144feabdc0.html. Accessed 19 Jan 2016.
205. Thompson PM, Stein JL, Medland SE, Hibar DP, Vasquez AA, Renteria ME, et al. The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav. 2014;8:153–82.
206. Tournier M. Current antipsychotic drug treatment may increase the risk of pulmonary embolism. Evid Based Ment Health. 2015;18:115.
207. Townsend L, Walkup JT, Crystal S, Olfson M. A systematic review of validated methods for identifying depression using administrative data. Pharmacoepidemiol Drug Saf. 2012;21(Suppl 1):163–73.
208. Valenza G, Nardelli M, Lanata A, Gentili C, Bertschy G, Paradiso R, et al. Wearable monitoring for mood recognition in bipolar disorder based on history-dependent long-term heart rate variability analysis. IEEE J Biomed Health Inform. 2014;18:1625–35.
209. Varian HR. Beyond big data. Bus Econ. 2014;49:27–31.
210. Vigod SN, Kurdyak PA, Seitz D, Herrmann N, Fung K, Lin E, et al. READMIT: a clinical risk index to predict 30-day readmission after discharge from acute psychiatric units. J Psychiatr Res. 2015;61:205–13.
211. Wang X, Wang F, Hu J, Sorrentino R. Exploring joint disease risk prediction. AMIA Annu Symp Proc. 2014;2014:1180–7.
212. Ware JH. The limitations of risk factors as prognostic tools. N Engl J Med. 2006;355:2615–7.
213. Waters R. Tech firms have high hopes for new year. Financial times. 2015. http://www.ft.com/cms/s/0/c7da2042-77ce-11e5-a95a-27d368e1ddf7.html#axzz3v6YjTcW2. Accessed 19 Jan 2016.
214. Webb RT, Lichtenstein P, Larsson H, Geddes JR, Fazel S. Suicide, hospital-presenting suicide attempts, and criminality in bipolar disorder: examination of risk for multiple adverse outcomes. J Clin Psychiatry. 2014;75:e809–16.
215. West SL, Johnson W, Visscher W, Kluckman M, Qin Y, Larsen A. The challenges of linking health insurer claims with electronic medical records. Health Informatics J. 2014;20:22–34.
216. Westman J, Hällgren J, Wahlbeck K, Erlinge D, Alfredsson L, Osby U. Cardiovascular mortality in bipolar disorder: a population-based cohort study in Sweden. BMJ Open. 2013;3(4):e002373. doi:10.1136/bmjopen-2012-002373
217. Wharam JF, Weiner JP. The promise and peril of healthcare forecasting. Am J Manag Care. 2012;18:e82–5.
218. Wilson J, Bock A. The benefit of using both claims data and electronic medical record data in health care analysis. Eden Prairie MN: Optum; 2012. https://www.optum.com/content/dam/optum/resources/whitePapers/Benefits-of-using-both-claims-and-EMR-data-in-HC-analysis-WhitePaper-ACS.pdf. Accessed 19 Jan 2016.
219. Wium-Andersen MK, Ørsted DD, Nordestgaard BG. Elevated C-reactive protein and lateonset bipolar disorder in 78,809 individuals from the general population. Br J Psychiatry. 2015;208(2):138–45 (Epub ahead of print).
220. Woltmann E, Grogan-Kaylor A, Perron B, Georges H, Kilbourne AM, Bauer MS. Comparative effectiveness of collaborative chronic care models for mental health conditions across primary, specialty, and behavioral health care settings: systematic review and meta-analysis. Am J Psychiatry. 2012;169(8):790–804.
221. Wotton CJ, Goldacre MJ. Record-linkage studies of the coexistence of epilepsy and bipolar disorder. Soc Psychiatry Psychiatr Epidemiol. 2014;49:1483–8.
222. Wray NR, Yang J, Hayes BJ, Price AL, Goddard ME, Visscher PM. Pitfalls of predicting complex traits from SNPs. Nat Rev Genet. 2013;14:507–15.
223. Wu J, Roy J, Stewart WF. Prediction modeling using EHR data: challenges, strategies, and a comparison of machine learning approaches. Med Care. 2010;48(6 Suppl):S106–13.
224. Wu SI, Chen SC, Juang JJ, Fang CK, Liu SI, Sun FJ, et al. Diagnostic procedures, revascularization, and inpatient mortality after acute myocardial infarction in patients with schizophrenia and bipolar disorder. Psychosom Med. 2013;75:52–9.
225. Wyss R, Stürmer T. Commentary: balancing automated procedures for confounding control with background knowledge. Epidemiology. 2014;25:279–81.
226. Yang SY, Liao YT, Liu HC, Chen WJ, Chen CC, Kuo CJ. Antipsychotic drugs, mood stabilizers, and risk of pneumonia in bipolar disorder: a nationwide case-control study. J Clin Psychiatry. 2013;74:e79–86.
227. Young AH, Rigney U, Shaw S, Emmas C, Thompson JM. Annual cost of managing bipolar disorder to the UK healthcare system. J Affect Disord. 2011;133:450–6.
228. Zhang Y, Adams AS, Ross-Degnan D, Zhang F, Soumerai SB. Effects of prior authorization on medication discontinuation among medicaid beneficiaries with bipolar disorder. Psychiatr Serv. 2009;60:520–7.